Published in BMC Genomics on October 11, 2010
In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet (2011) 1.69
Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy. Cardiovasc Res (2013) 1.25
Proteomics: from single molecules to biological pathways. Cardiovasc Res (2012) 0.86
Functional and topological properties in hepatocellular carcinoma transcriptome. PLoS One (2012) 0.86
Functional Genomics Assistant (FUGA): a toolbox for the analysis of complex biological networks. BMC Res Notes (2011) 0.85
Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy. Physiol Genomics (2011) 0.84
The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms. Cancer (2011) 0.81
EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical Therapeutic Targets. Neuroendocrinology (2012) 0.80
Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors. BMC Genomics (2014) 0.79
Investigating core genetic-and-epigenetic cell cycle networks for stemness and carcinogenic mechanisms, and cancer drug design using big database mining and genome-wide next-generation sequencing data. Cell Cycle (2016) 0.76
Basic local alignment search tool. J Mol Biol (1990) 659.07
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
Autophagy in the pathogenesis of disease. Cell (2008) 34.68
Community structure in social and biological networks. Proc Natl Acad Sci U S A (2002) 29.77
Lethality and centrality in protein networks. Nature (2001) 29.64
An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res (2002) 25.81
Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A (2002) 25.47
Specificity and stability in topology of protein networks. Science (2002) 21.07
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell (2005) 21.01
NCBI GEO: mining tens of millions of expression profiles--database and tools update. Nucleic Acids Res (2006) 19.42
A gene-coexpression network for global discovery of conserved genetic modules. Science (2003) 18.75
ArrayExpress update--from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res (2008) 12.45
Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol (2006) 10.71
An overview of Ensembl. Genome Res (2004) 10.35
STRING: a database of predicted functional associations between proteins. Nucleic Acids Res (2003) 9.45
Coexpression analysis of human genes across many microarray data sets. Genome Res (2004) 9.38
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med (2007) 8.82
Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res (2007) 8.44
Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J Cell Biol (2001) 7.68
Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Proc Natl Acad Sci U S A (2006) 5.69
The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol (2007) 5.63
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest (2005) 5.48
Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res (2010) 5.08
Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet (2007) 4.69
Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest (2005) 4.31
Akt1 is required for physiological cardiac growth. Circulation (2006) 4.25
Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation (2005) 3.86
Web services at the European Bioinformatics Institute-2009. Nucleic Acids Res (2009) 3.78
Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res (2004) 3.72
Cysteine desulfurase activity indicates a role for NIFS in metallocluster biosynthesis. Proc Natl Acad Sci U S A (1993) 3.59
Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation (2003) 3.20
Construction, visualisation, and clustering of transcription networks from microarray expression data. PLoS Comput Biol (2007) 2.73
Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis. Nat Genet (2007) 2.47
TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med (2000) 2.29
Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. Hum Mol Genet (1996) 2.29
Protein families and TRIBES in genome sequence space. Nucleic Acids Res (2003) 2.27
Human gene coexpression landscape: confident network derived from tissue transcriptomic profiles. PLoS One (2008) 2.09
Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles. Nat Genet (2001) 1.93
Oxygen activation and reduction in respiration: involvement of redox-active tyrosine 244. Science (2000) 1.89
Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A (2007) 1.82
Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol (2005) 1.78
COmplete GENome Tracking (COGENT): a flexible data environment for computational genomics. Bioinformatics (2003) 1.77
Homology of the NifS family of proteins to a new class of pyridoxal phosphate-dependent enzymes. FEBS Lett (1993) 1.69
LGL: creating a map of protein function with an algorithm for visualizing very large biological networks. J Mol Biol (2004) 1.65
Gene expression profiling of exercise-induced cardiac hypertrophy in rats. Acta Physiol Scand (2005) 1.55
Systematic construction of gene coexpression networks with applications to human T helper cell differentiation process. Bioinformatics (2007) 1.54
Regulation of the TAK1 signaling pathway by protein phosphatase 2C. J Biol Chem (2000) 1.44
Friedreich ataxia. Arch Neurol (2008) 1.40
Physiological myocardial hypertrophy: how and why? Front Biosci (2008) 1.35
Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. Physiol Genomics (2004) 1.31
Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proc Natl Acad Sci U S A (2009) 1.31
Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat Cell Biol (2009) 1.27
The "athletic heart". Prevalence and physiological significance of left ventricular enlargement in distance runners. JAMA (1976) 1.24
Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. Physiol Genomics (2006) 1.23
Topological and functional discovery in a gene coexpression meta-network of gastric cancer. Cancer Res (2006) 1.22
Cardiac adaptations to chronic exercise in mice. Am J Physiol (1994) 1.13
Domain architecture of the regulators of calcineurin (RCANs) and identification of a divergent RCAN in yeast. Mol Cell Biol (2009) 1.07
Meta-analysis of inter-species liver co-expression networks elucidates traits associated with common human diseases. PLoS Comput Biol (2009) 0.99
Identification and characterization of a RING zinc finger gene (C-RZF) expressed in chicken embryo cells. Proc Natl Acad Sci U S A (1996) 0.91
RNF13: a novel RING-type ubiquitin ligase over-expressed in pancreatic cancer. Cell Res (2009) 0.87
Meta-coexpression conservation analysis of microarray data: a "subset" approach provides insight into brain-derived neurotrophic factor regulation. BMC Genomics (2009) 0.80
An overview of cardiac systems biology. J Mol Cell Cardiol (2008) 0.80
The association of split hand foot malformation (SHFM) and congenital heart defects. Birth Defects Res A Clin Mol Teratol (2008) 0.78
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science (2013) 10.87
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A (2010) 7.77
Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res (2005) 7.13
Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet (2012) 6.97
Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med (2013) 4.74
Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res (2012) 4.19
Modeling the percolation of annotation errors in a database of protein sequences. Bioinformatics (2002) 4.12
Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol (2003) 3.73
Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol (2004) 3.27
Detection of functional modules from protein interaction networks. Proteins (2004) 3.08
Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet (2004) 3.07
Redox signaling in cardiac physiology and pathology. Circ Res (2012) 2.98
NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal (2006) 2.95
Genome-wide identification of genes likely to be involved in human genetic disease. Nucleic Acids Res (2004) 2.86
Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res (2002) 2.79
Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc Res (2005) 2.79
Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol (2010) 2.72
Comparative genomics of transcriptional control in the human malaria parasite Plasmodium falciparum. Genome Res (2004) 2.66
Evaluation of annotation strategies using an entire genome sequence. Bioinformatics (2003) 2.66
Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation (2002) 2.57
Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res (2003) 2.50
Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler Thromb Vasc Biol (2011) 2.44
The balance of driving forces during genome evolution in prokaryotes. Genome Res (2003) 2.39
NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A (2010) 2.36
The net of life: reconstructing the microbial phylogenetic network. Genome Res (2005) 2.31
Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart (2006) 2.28
Protein families and TRIBES in genome sequence space. Nucleic Acids Res (2003) 2.27
BioLayout(Java): versatile network visualisation of structural and functional relationships. Appl Bioinformatics (2005) 2.26
Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension (2002) 2.20
The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem (2011) 2.20
Genome evolution reveals biochemical networks and functional modules. Proc Natl Acad Sci U S A (2003) 2.08
Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem (2002) 2.05
Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. Circ Heart Fail (2011) 1.96
Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. Genome Res (2004) 1.92
The phylogenetic extent of metabolic enzymes and pathways. Genome Res (2003) 1.92
Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J (2006) 1.90
Activation of p38 mitogen-activated protein kinase contributes to the early cardiodepressant action of tumor necrosis factor. J Am Coll Cardiol (2006) 1.89
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res (2006) 1.88
Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Res Cardiol (2011) 1.87
Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? Basic Res Cardiol (2011) 1.81
Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. Circ Res (2013) 1.81
Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: Evidence for tissue specificity of leptin resistance. Eur Heart J (2006) 1.81
Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arterioscler Thromb Vasc Biol (2008) 1.77
COmplete GENome Tracking (COGENT): a flexible data environment for computational genomics. Bioinformatics (2003) 1.77
Myriads of protein families, and still counting. Genome Biol (2003) 1.75
Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension (2008) 1.68
Transcription regulation and environmental adaptation in bacteria. Trends Microbiol (2003) 1.63
Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts. Circ Res (2013) 1.62
Redox signaling in cardiac myocytes. Free Radic Biol Med (2011) 1.62
Measuring genome conservation across taxa: divided strains and united kingdoms. Nucleic Acids Res (2005) 1.61
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2009) 1.61
Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J Biol Chem (2003) 1.60
Role of phosphoinositide 3-kinase {alpha}, protein kinase C, and L-type Ca2+ channels in mediating the complex actions of angiotensin II on mouse cardiac contractility. Hypertension (2010) 1.59
NADPH oxidase and endothelial cell function. Clin Sci (Lond) (2005) 1.58
IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes (2007) 1.56
Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol (2002) 1.54
Effect of endothelium-specific insulin resistance on endothelial function in vivo. Diabetes (2008) 1.52
Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling. Circulation (2012) 1.51
Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction. Diabetes (2013) 1.51
Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol (2005) 1.50
Strain-dependent variation in vascular responses to nitric oxide in the isolated murine heart. J Mol Cell Cardiol (2002) 1.49
Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol (2002) 1.47
The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg (2007) 1.46
Peroxidasin-like protein: a novel peroxidase homologue in the human heart. Cardiovasc Res (2013) 1.46
ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol (2003) 1.45
Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res (2008) 1.44
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2011) 1.40
NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol (2006) 1.39
Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. FASEB J (2005) 1.38
Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation (2012) 1.36
Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy. Cancer Res (2010) 1.35
Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. Circulation (2008) 1.34
MagicMatch--cross-referencing sequence identifiers across databases. Bioinformatics (2005) 1.34
Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol (2006) 1.34
Highly consistent patterns for inherited human diseases at the molecular level. Bioinformatics (2005) 1.33
An exponential core in the heart of the yeast protein interaction network. Mol Biol Evol (2004) 1.31
Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation. Circulation (2004) 1.31
Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res (2007) 1.31
Structural and functional properties of genes involved in human cancer. BMC Genomics (2006) 1.29
Role of Nox4 in murine models of kidney disease. Free Radic Biol Med (2012) 1.28
The phylogenetic diversity of eukaryotic transcription. Nucleic Acids Res (2003) 1.28
Sequence-based feature prediction and annotation of proteins. Genome Biol (2009) 1.28
NADPH oxidases in heart failure: poachers or gamekeepers? Antioxid Redox Signal (2012) 1.27
Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. Circulation (2009) 1.27
Percolation of annotation errors through hierarchically structured protein sequence databases. Math Biosci (2005) 1.27
Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4. J Biol Chem (2011) 1.26
Genome coverage, literally speaking. The challenge of annotating 200 genomes with 4 million publications. EMBO Rep (2005) 1.25
Functional evolution of the yeast protein interaction network. Mol Biol Evol (2004) 1.25
Involvement of NADPH oxidase in age-associated cardiac remodeling. J Mol Cell Cardiol (2010) 1.25
Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice. Nat Commun (2012) 1.25
Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol (2007) 1.24
GeneTRACE-reconstruction of gene content of ancestral species. Bioinformatics (2003) 1.23
NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol (2011) 1.23
Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension (2010) 1.23